Translational Development Acquisition Corp. - Class A ordinary share, par value $0.0001 (TDACU)

CUSIP: G9008W121

Q4 2024 13F Holders as of 31 Dec 2024

Type / Class
Equity / Class A ordinary share, par value $0.0001
Shares outstanding
17,264,276
Total 13F shares
15,028,755
Share change
+14,943,755
Total reported value
$150,646,354
Price per share
$10.02
Number of holders
42
Value change
+$149,794,654
Number of buys
41

Quarterly Holders Quick Answers

What is CUSIP G9008W121?
CUSIP G9008W121 identifies TDACU - Translational Development Acquisition Corp. - Class A ordinary share, par value $0.0001 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Translational Development Acquisition Corp. - Class A ordinary share, par value $0.0001 (TDACU) as of Q4 2024

As of 31 Dec 2024, Translational Development Acquisition Corp. - Class A ordinary share, par value $0.0001 (TDACU) was held by 42 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 15,028,755 shares. The largest 10 holders included AQR Arbitrage LLC, Magnetar Financial LLC, HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND, LMR Partners LLP, Polar Asset Management Partners Inc., K2 PRINCIPAL FUND, L.P., Hudson Bay Capital Management LP, First Trust Capital Management L.P., TENOR CAPITAL MANAGEMENT Co., L.P., and Linden Advisors LP. This page lists 42 institutional shareholders reporting positions in this security for the Q4 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.